- Life Sciences
Amanda Abbott is a San Diego attorney specializing in healthcare and life sciences. Amanda draws upon her prior experiences as a nurse, litigator, and in-house corporate counsel to provide uniquely pragmatic yet comprehensive legal services and strategic guidance to clients.
Amanda excels at structuring transactions that establish symbiotic business and research relationships for healthcare providers and biotech companies. Her approach successfully facilitates new technology development and integration into clinical care. By advising both start-ups and decades-old institutions, Amanda is a creative and efficient resource to her clients.
For many years, Amanda served as a key advisor in the establishment and growth of research and clinical operations at Rady Children’s Institute for Genomic Medicine. Its rapid growth achieved record-setting whole genome sequencing and recognition as a leader in translational medicine research and implementation.
As a partner at Vanst, Amanda applies her understanding of healthcare issues to enable bench-to-bedside relationships that are vital to innovation in healthcare. She brings to every transactional matter a deep knowledge of health information and data privacy and security, nonprofit tax-exempt transactions, healthcare reimbursement, clinical trials, fraud and abuse (false claims, anti-kickback, Stark), intellectual property and technology licensing, integrated delivery networks, managed care, and government regulatory mechanisms.
For nearly a decade, Amanda was corporate counsel to Rady Children’s Hospital and Health Center. Her primary responsibilities included handling healthcare and life sciences business transactions, clinical services and operations transactions, regulatory compliance guidance, reimbursement litigation oversight, and strategic advising for the Rady Children’s entities, including Rady Children’s Health Network, Rady Children’s Specialists, Rady Children’s Physician Management Services, Rady Children’s Hospital Foundation, and the Rady Children’s Institute for Genomic Medicine.
Before her tenure at Rady Children’s, Amanda was a healthcare attorney with the litigation, transactional, and regulatory groups at Hooper, Lundy & Bookman, P.C. Prior to that she was a litigation associate at Neil Dymott, a consultant on toxic tort class actions and a summer associate at Drinker Biddle & Reath in San Francisco. She began her career as a clinical care provider including most notably as a neonatal intensive care unit nurse at the University of California, San Francisco Medical Center.
Amanda is an alumnus of the University of California, Davis, King Hall School of Law, and the University of Pennsylvania.
- American Health Lawyers Association (AHLA) (2004-present)
- Association of Corporate Counsel (2014-present)
- California Society for Healthcare Attorneys (CSHA) (2005-2017) (Membership Committee 2011-2013)
- American Association of Nurse Attorneys (TAANA) (2003-2013)
- San Diego County Bar Association (Law & Medicine Committee)
- Lawyers Club of San Diego (2003-2014)
- Sharp Healthcare Bioethics Committee (2006-2011)
- “HIPAA Updates,” San Diego County Bar Association, September 28, 2011
- “HIPAA Update: New Compliance Requirements for Business Associates,” San Diego Legal Secretaries’ Association, June 28, 2010
- “How the Federal Stimulus Package Affects the Health Care Industry,” San Diego County Bar Association, June 11, 2009
- “Resident Abuse & Reporting,” Council for Long Term Care Nurses of California Annual Seminar, October 19, 2006
- “Extending HIPAA’s Reach to Subcontractors May Impact California Litigation Practices,” Vol. 29 California Health Law News (Summer 2011).
- Patric Hooper & Amanda Abbott, Health Care Fraud and Abuse: Practical Perspectives, Ch. 4: Practical Considerations for Defending Health Care Fraud and Abuse Cases (L. Baumann ed., 2d ed. 2007 & Supps. 2008 & 2009).
- “New End of Life Care Requirements for Hospitals,” Vol. 11 Health Law Perspectives No. 4 (April 2009).
- “Special Report: HR 1- The American Recovery Reinvestment Act” (Contributing Writer), Health Law Perspectives (March 2009).
- “Employing or Contracting With an Excluded Individual Risky for Providers,” Vol. 8 Health Law Perspectives No. 9 (Dec. 2006)